The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS)
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is one of the most common of all medical disorders worldwide and, while for some it represents no more than a nuisance, for others it imposes significant negative impacts on daily life and activities. IBS is a heterogeneous disorder and may well have a number of causes which may lie anywhere from the external environment to the contents of the gut lumen and from the enteric neuromuscular apparatus and the gut immune system to the central nervous system. Consequently, the paradigm of the gut-brain axis, which includes the participation of these various factors, has proven a useful model to assist clinicians and patients alike in understanding the genesis of symptoms in IBS. Now, given the widespread interest in the gut microbiome in health and disease, in general, reports of disordered enteric bacterial communities in IBS, and experimental data to indicate that components of the gut microbiota can influence brain morphology and function, as well as behavior and cognition, this concept has been extended to encompass the microbiota-gut-brain axis. The implications of this novel concept to the assessment and management of IBS will be explored in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“Other routes of influence, including the vagus nerve and microbial metabolites, have also been invoked [46] based on studies in animal models.”
BackgroundLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748
Gut feelings: the emerging biology of gut-brain communication
Mayer, E. A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3071 · Cited by 1,726 · cited 1×
“Interactions between brain and gut extend well beyond the bounds of the stressed, anxious or depressed gut and should also encompass situations where the brain, the gut and their linkage, through the autonomic nervous system, are affected by the same pathologic process, as in Parkinson’s disease (PD) as well as those…”
BackgroundConsumption of fermented milk product with probiotic modulates brain activity
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · cited 1×
“The limited data that is available is encouraging and suggests that, not only that the axis is operative, but also that its modulation may be therapeutically beneficial [49,50].”
BackgroundMicrobiota is essential for social development in the mouse
Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.65 · Cited by 866
Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F.-P., Cominetti, O., Welsh, C., Rieder, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.003 · Cited by 821
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Self-citationFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · cited 1×
“The poorly absorbed antibiotic rifaximin [39] and probiotics, in general [40], have been shown to ameliorate the cardinal symptoms of IBS.”
BackgroundSelf-citation
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Black, C. J., & Ford, A. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0286-8 · Cited by 610
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Simon, E., Călinoiu, L. F., Mitrea, L., & Vodnar, D. C. (2021) · Nutrients · doi:10.3390/nu13062112 · Cited by 213
“However, there is a missing link in the precise differentiation of small intestinal bacterial overgrowth in IBS due to the current limitations of methodologies, such as jejunal aspiration and the breath test [11,159].”
BackgroundJeffery, I. B., Das, A., O’Herlihy, E., Coughlan, S., Cisek, K., Moore, M., Bradley, F., Carty, T., Pradhan, M., Dwibedi, C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.301 · Cited by 202
The gut Microbiome in adult and pediatric functional gastrointestinal disorders
Shin, A., Preidis, G. A., Shulman, R., & Kashyap, P. C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.054 · Cited by 163
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis
Person, H., & Keefer, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110209 · Cited by 158
“Perturbations in the gut microbiome are believed to be part of the pathogenesis of various gastrointestinal diseases, including IBD and IBS as well as influencing metabolism and contributing to obesity (C. D. Davis, 2016; Quigley, 2018; Zuo and Ng, 2018).”
BackgroundKUWAHARA, A., MATSUDA, K., KUWAHARA, Y., ASANO, S., INUI, T., & MARUNAKA, Y. (2020) · Biomedical Research · doi:10.2220/biomedres.41.199 · Cited by 112
“Irritable bowel syndrome (IBD) is related to stress-related psychiatric disorders, including major depression and anxiety and is recognized as a disorder of the gut-brainaxis (Collins 2014; Quigley 2018).”
BackgroundPsychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02053-3 · Cited by 130
“The gut-brain axis is bidirectional association between the gastrointestinal system and the CNS that coordinates the functions of the ENS and CNS (Fichna and Storr 2012; Quigley 2018).”
BackgroundDong, X., Yi, X., Gao, D., Gao, Z., Huang, S., Chao, M., Chen, W., & Ding, M. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1183-0 · Cited by 97
Feeding melancholic microbes: MyNewGut recommendations on diet and mood
Dinan, T. G., Stanton, C., Long-Smith, C., Kennedy, P., Cryan, J. F., Cowan, C. S. M., Cenit, M. C., van der Kamp, J.-W., & Sanz, Y. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.010 · Cited by 95
“Several placebo controlled studies indicate that a bifidobacteria is highly effective in treating the condition [55].”
BackgroundAntibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Mamieva, Z. A., Poluektova, E. A., Свистушкин, В. М., Sobolev, V., Shifrin, O. S., Guarner, F., & Ivashkin, V. T. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i12.1204 · Cited by 110
Enteric Glia: A New Player in Abdominal Pain
Morales‐Soto, W., & Gulbransen, B. D. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.11.005 · Cited by 88
Rodríguez-Daza, M.-C., & de Vos, W. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010045 · Cited by 97
“Deviations in the composition and functions of the gut microbiota have been associated with many diseases, including gastrointestinal, cardiovascular [3–6], hepatic [7], immunological, and neurological disorders [8,9].”
BackgroundGut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2022) · Kompass Nutrition & Dietetics · doi:10.1159/000523712 · Cited by 87
“Gut-brain communication is disrupted in the cases of IBS and microbial dysbiosis [58], in the former leading to changes in intestinal motility and secretion and causing visceral hypersensitivity (hyperalgesia) [59].”
BackgroundOoi, S. L., Correa, D., & Pak, S. C. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.01.010 · Cited by 83
Xu, H., Ma, C., Zhao, F., Chen, P., Liu, Y., Sun, Z., Cui, L., Kwok, L. Y., & Zhang, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02437-4 · Cited by 64
Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis
Ding, L., Ning, L., & Xu, G. (2019) · Medicine · doi:10.1097/md.0000000000016068 · Cited by 71
“Probiotics, defined as live microorganisms, could change intestinal flora to regulate intestinal function such as to reduce visceral hypersensitivity,([5]) improve the mucosal barrier function, modulate immunity and chronic inflammation,([6,7]) communicate with central nervous system,([8]) influence the gastrointestin…”
BackgroundMari, A., Baker, F. A., Mahamid, M., Sbeit, W., & Khoury, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030685 · Cited by 61
“, mutation in the SC5NA gene encoding a sodium channel ion; a number of singlenucleotide polymorphism studies have also identified polymorphisms in genes associated with IBS pathogenesis including genes coding for serotonin signaling, immune regulation, and epithelial barrier function), and the evolving c ncept of dys…”
BackgroundMinerbi, A., González, E., Brereton, N. J. B., Fitzcharles, M., Chevalier, S., & Shir, Y. (2022) · Pain · doi:10.1097/j.pain.0000000000002694 · Cited by 44
Zhou, Z., Hui, E. S. K., Kranz, G. S., Chang, J. R., de Luca, K. E., Pinto, S. M., Chan, W. W. Y., Yau, S., Chau, B. K. H., Samartzis, D., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101767 · Cited by 48
“…has been widely reported in people with various chronic pain conditions, such as irritable bowel syndrome (El-Salhy et al., 2020; Liu et al., 2017; Quigley, 2018), chronic pelvic pain (Janulewicz et al., 2019), and fibromyalgia (Clos-Garcia et al., 2019; Goebel et al., 2008; Pimentel et al.,…”
BackgroundA Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet
Roncoroni, L., Elli, L., Doneda, L., Bascuñán, K. A., Vecchi, M. L., Morreale, F., Scricciolo, A., Lombardo, V., & Pellegrini, N. (2018) · Nutrients · doi:10.3390/nu10111769 · Cited by 44
“The pathogenesis of IBS is multi-factorial and may be connected to visceral hyper-sensitivity, alterations of the gut-brain axis and the microbiota, post infectious consequences, and environmental and genetic factors [13].”
BackgroundHawrelak, J. A., Wohlmuth, H., Pattinson, M., Myers, S. P., Goldenberg, J. Z., Harnett, J., Cooley, K., Venter, C. V. D., Reid, R., & Whitten, D. L. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102233 · Cited by 47
General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction
Liu, L., Shang, L., Jin, D., Wu, X., & Long, B. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06096-7 · Cited by 50
“2017; Quigley 2018; Askarova et al.”
Phoenixin—A Pleiotropic Gut-Brain Peptide
Schalla, M. A., & Stengel, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061726 · Cited by 49
“, by manipulation of the microbiota might improve the clinical course in patients [7].”
BackgroundYelverton, C. A., Rafferty, A., Moore, R., Byrne, D. F., Mehegan, J., Cotter, P. D., van Sinderen, D., Murphy, E. F., Killeen, S. L., & McAuliffe, F. M. (2022) · Nutrition · doi:10.1016/j.nut.2021.111582 · Cited by 53
Wu, H., Zhan, K., Rao, K., Zheng, H., Qin, S., Tang, X., & Huang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112811 · Cited by 42
Raman, M., Vishnubhotla, R. V., Ramay, H. R., Gonçalves, M. C. B., Shin, A., Pawale, D., Subramaniam, B., & Sadhasivam, S. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03935-8 · Cited by 37
Dietary modulation of gut microbiota for the relief of irritable bowel syndrome
Kim, M.-Y., & Choi, S. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.4.411 · Cited by 30
“Since the fact that brain can disturb intestinal function, IBS symptoms have been considered rather as a psychologic manifestation [30].”
BackgroundKarakuła‐Juchnowicz, H., Gałęcka, M., Róg, J., Bartnicka, A., Łukaszewicz, Z., Krukow, P., Morylowska-Topolska, J., Skonieczna‐Żydecka, K., Krajka, T., Jonak, K., et al. (2018) · Nutrients · doi:10.3390/nu10050548 · Cited by 32
Microbiota Gut–Brain Axis and Autism Spectrum Disorder: Mechanisms and Therapeutic Perspectives
Petropoulos, A., Stavropoulou, E., Tsigalou, C., & Bezirtzoglou, E. (2025) · Nutrients · doi:10.3390/nu17182984 · Cited by 45
“Neuroanatomical, neuroendocrine, immunological, metabolic, and microbial metabolite pathways are key components [9].”
Malagelada, J. R. (2020) · Digestive Diseases · doi:10.1159/000505810 · Cited by 29
Șchiopu, C. G., Ștefănescu, C., Boloș, A., Diaconescu, S., Gîlcă-Blanariu, G.-E., & Ștefănescu, G. (2022) · Microorganisms · doi:10.3390/microorganisms10112199 · Cited by 29
“Through these pathways, there is a bidirectional regulation and influence over cognitive, emotion, behavior on one side and the functionality of the gastrointestinal system, with all roles involved: digestion, absorption and enteric immune system [2,3].”
BackgroundYelverton, C. A., Killeen, S. L., Feehily, C., Moore, R., Callaghan, S. L., Geraghty, A. A., Byrne, D. F., Walsh, C. J., Lawton, E. M., Murphy, E. F., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1154114 · Cited by 25
“The gut brain axis is a bidirectional pathway by which the enteric and central nervous systems communicate, linking intestinal function to emotional and cognitive centers of the brain (Quigley, 2018).”
BackgroundSinagra, E., Pellegatta, G., Guarnotta, V., Maida, M. F., Rossi, F., Conoscenti, G., Pallio, S., Alloro, R., Raimondo, D., Pace, F., et al. (2021) · Life · doi:10.3390/life11070715 · Cited by 26
“Researchers have identified changes in gut microbiota composition of in several diseases, such as inflammatory bowel disease [11], irritable bowel syndrome [12], diabetes [13], cancer [14], and diseases of the nervous system, such as Alzheimer’s disease [15], Parkinson’s disease (PD) [16], spinal cord injury [17], aut…”
BackgroundNa, W., Lee, Y., Kim, H., Kim, Y. S., & Sohn, C. (2021) · Nutrients · doi:10.3390/nu13041308 · Cited by 25
Medicinal Plants, Phytochemicals, and Their Impacts on the Maturation of the Gastrointestinal Tract
Mukonowenzou, N. C., Adeshina, K. A., Donaldson, J., Ibrahim, K. G., Usman, D., & Erlwanger, K. H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.684464 · Cited by 26
“This axis is a bidirectional communication between the central nervous system and the enteric nervous system (Quigley, 2018; Tait and Sayuk, 2021).”
BackgroundAberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Dhonnabháín, R. N., Xiao, Q., & O’Malley, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745190 · Cited by 28
Bednarska, O., Biskou, O., Israelsen, H., Winberg, M. E., Walter, S., & Keita, Å. V. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1004084 · Cited by 25
“Nevertheless, increasing evidence strongly supports that disturbed intestinal barrier function and altered microbiota and immune activation contribute to IBS pathophysiology (11, 12).”
BackgroundTreating irritable bowel syndrome through an interdisciplinary approach
Nelkowska, D. D. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0441 · Cited by 28
“CNS disorders are also connected with autonomic nervous system (ANS) malfunction.”
BackgroundInfluentialLi, J., He, P., Lu, X., Guo, Y., Liu, M., Li, G., & Ding, J. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20209 · Cited by 23
“The occurrence of IBS is associated with gastrointestinal motility abnormalities, visceral hypersensitivity, intestinal inflammation, and psychological disorders, which can influence IBS symptoms through brain-gut interaction.(2) Almost half of IBS patients suffer from psychological-psychiatric disorders, such as depr…”
BackgroundO’Brien, R., & O’Malley, D. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13738 · Cited by 24
Bruzzese, E., Pesce, M., Sarnelli, G., & Guarino, A. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1488964 · Cited by 22
Aigbologa, J., Connolly, M., Buckley, J. M., & O’Malley, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00436 · Cited by 17
Stachowska, E., Maciejewska, D., Ryterská, K., Baszuk, P., Skonieczna‐Żydecka, K., Czerwińska-Rogowska, M., Palma, J., Gudan, A., Mruk, H., Wolska, A., et al. (2018) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.274.pol · Cited by 16
“These data also add to the evidence of the importance of gut-brain communication and its role in the development of gastrointestinal symptoms [34].”
BackgroundDoes the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?
Fagoonee, S., & Pellicano, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111808 · Cited by 20
“This issue has been accurately discussed in a recent review by Quigley [14].”
BackgroundMarteau, P. R., Nevé, B. L., Quinquis, L., Pichon, C., Whorwell, P. J., & Guyonnet, D. (2019) · Nutrients · doi:10.3390/nu11010092 · Cited by 15
“14 Furthermore, the observation that the intestinal and central aspects of the disorder can be transmitted by faecal transplantation in animal models and potentially modulated by probiotics, especially bifidobacteria, opens space for the development of new treatments [5,6,14].”
BackgroundEditorial: Human Microbiome: Symbiosis to Pathogenesis
Lee, L., Wong, S. H., Chin, S., Singh, V., & Mutalib, N. A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.605783 · Cited by 22
“…as to how microbes in the gut communicate with neurons in the brain that drives behavioral or emotional changes, but more clues are emphasizing the importance of the gut–brain axis (Foster and Neufeld, 2013; Kennedy et al., 2014; Lee et al., 2018, 2019; Quigley, 2018; Johnson et al., 2020).”
BackgroundNeuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome
Stănculete, M. F., Dumitrascu, D. L., & Drossman, D. A. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4090 · Cited by 22
Rosa, D., Zablah, R. A., & Vázquez-Frías, R. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1283389 · Cited by 17
Soufan, F., Ghosson, A., Jaber, R. A., Ghandour, A., & Uwishema, O. (2025) · Health Science Reports · doi:10.1002/hsr2.70660 · Cited by 21
“New studies have demonstrated that IBS has a particular sensitivity to stressors unlike other disorders [45].”
InfluentialPotential of natural products in the treatment of irritable bowel syndrome
Lü, Q., Tan, D., Luo, J., Ye, Y., Zuo, M., Wang, S., & Li, C. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154419 · Cited by 12
Heenan, P. E., Creemers, R. H., Sharma, S., Keenan, J. I., Bayer, S. B., Young, W., Cooney, J. M., Armstrong, K., Fraser, K., Skidmore, P. M. L., et al. (2020) · Inflammatory Intestinal Diseases · doi:10.1159/000508160 · Cited by 15
Oortwijn, W., & Sampietro-Colom, L. (2022) · Radboud University Press eBooks · doi:10.54195/ckhb1659 · Cited by 14
Akbari, R., Salimi, Y., Dehghani-Arani, F., & Rezayat, E. (2025) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112067 · Cited by 15
Barazanji, N., Hamilton, J. P., Icenhour, A., Simon, R. A., Bednarska, O., Tapper, S., Tisell, A., Lundberg, P., Engström, M., & Walter, S. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103128 · Cited by 13
Pagán-Busigó, J. E., López-Carrasquillo, J., Appleyard, C. B., & Torres-Reverón, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264909 · Cited by 12
Microbiota-gut-liver-brain axis and hepatic encephalopathy
Lu, H., Zhang, H., Wu, Z., & Li, L. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2023.44 · Cited by 19
Microbiome: A Key Regulator of Body-Brain Interactions
O’Riordan, K. J., Aburto, M. R., Nagpal, J. K., Clarke, G. A., & Cryan, J. F. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_6 · Cited by 10
Gut microbiome and neurosurgery: Implications for treatment
Willman, J., Willman, M., Reddy, R., Fusco, A. F., Sriram, S., Mehkri, Y., Charles, J. H., Goeckeritz, J., & Lucke-Wold, B. P. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.139 · Cited by 10
Microbiome and Colorectal Cancer Management
Alrahawy, M., Javed, S., Atif, H., ElSanhoury, K., Mekhaeil, K., & Eskander, G. H. (2022) · Cureus · doi:10.7759/cureus.30720 · Cited by 12
“Obesity, diabetes, irritable bowel syndrome, IBD, depression, and cardiovascular disease are also studied for microbiome-based therapy [92-97].”
BackgroundHassan, D., Zahra, T., Kanaan, G., Khan, M. U., Mushtaq, K., Nashwan, A. J., & Hamid, P. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101459 · Cited by 9
Papaefthymiou, A., Doulberis, M., Kountouras, J., Kolokytha, C., Galanopoulos, M., Liatsos, C. N., Kyriakos, N., Giakoumis, M., Papadomichelakis, M., Pοlyzos, S. A., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001439 · Cited by 7
Faysal, M. F., Zehravi, M., Amin, M. A., Rab, S. O., Jahnavi, P., Arjun, U. V. N. V., Gupta, J. K., Billah, A. A. M., Vodeti, R., Prasad, P. D., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156090 · Cited by 7
Wilder‐Smith, C. H., Drewes, A. M., Materna, A., & Olesen, S. S. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000192 · Cited by 7
Prebiotic potential of melon (Cucumis melo L.) and watermelon (Citrullus lanatus) shell flours
Pérez‐Juárez, C. M., García-Ortíz, J. D., Flores‐Gallegos, A. C., González‐Herrera, S. M., Requena, M. C., Galindo, A. S., & Rodríguez-Herrera, R. (2024) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2024.100428 · Cited by 10
Effects of Novel Probiotics in a Murine Model of Irritable Bowel Syndrome
Chung, H. G., Min, Y. W., Lee, C., Hong, S. N., Won, J. Y., Jang, J. A., Kim, C.-H., & Chang, D. K. (2020) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2020.75.3.141 · Cited by 6
Li, Y., Li, Y.-R., Jin, Y., Li, M., Zhang, Q., Cao, J., Li, F., Zhang, H., Chen, J., & Li, Y.-Q. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102235 · Cited by 5
Cheung, S. L. Y., & Kenway, L. C. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/4520019 · Cited by 5
Abomoelak, B., Saps, M., Sudakaran, S., Deb, C., & Mehta, D. I. (2022) · BioTech · doi:10.3390/biotech11040050 · Cited by 5
“The role of the gut microbiome in the onset of the FAPDs symptoms remains largely unknown, but the link between the gut and the brain became a potential cause for some idiopathic diseases, such as IBS [32,33].”
BackgroundThe Intestinal Microbiome in Humans: Its Role for a Healthy Life and in the Onset of Diseases
Gașpar, B. S., Profir, M., Roşu, O. A., Ionescu, R. F., & Creţoiu, S. M. (2024) · Physiology · doi:10.5772/intechopen.113719 · Cited by 7
Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome
Joshi, D. C., Raina, N., Joshi, N., Gurow, K., Gwasakoti, J., Sood, A., Mehrotra, A., Tuli, H. S., Paudel, K. R., & Gupta, M. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70133 · Cited by 4
Biskou, O., Walter, S., Israelsen, H., Winberg, M. E., Bednarska, O., & Keita, Å. V. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1408623 · Cited by 6
Rurgo, S., Vaino, V., Andreozzi, M., Pagliaro, M., Senneca, P., Giorgio, G. D., Efficie, E., Sarnelli, G., & Pesce, M. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2022-0081 · Cited by 4
Irritable bowel syndrome and the gut microbiota
Heenan, P. E., Keenan, J. I., Bayer, S. B., Simon, M., & Gearry, R. B. (2019) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2019.1695635 · Cited by 4
“There is evidence of multiple biological system dysfunction in IBS patients compared to healthy controls, but current understanding of this disorder is that symptoms arise from dysregulation of the BGA © 2019 The Royal Society of New Zealand CONTACT Richard B. Gearry Richard.gearry@cdhb.govt.nz, Richard.Gearry@cdhb.he…”
BackgroundLehner, M. D., Ulsemer, P., & Christochowitz, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1569052 · Cited by 3
“Studies have shown that patients with IBS and FD often exhibit an altered gut microbiota composition compared to healthy individuals (Brown et al., 2022; Shanahan et al., 2023; Zhang et al., 2024b; Hillestad et al., 2022; Quigley, 2018; Gawey et al., 2024).”
A functional approach to the chronic disease epidemic
Hartzler, M. L., Castle, L., Lewis, C., & Zakaria, L. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa032 · Cited by 3
Li, Y., & Duan, Z. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2056018 · Cited by 3
Insights into the Characteristics and Functions of Mast Cells in the Gut
Guo, Y., Wang, B., Gao, H., He, C., Xin, S., Hua, R., Liu, X., Zhang, S., & Xu, J. (2023) · Gastroenterology Insights · doi:10.3390/gastroent14040043 · Cited by 3
Palanimurugan, P., Arumugam, V., Balakrishnan, A., Annamalai, G., Kuppusamy, M., Venkateswaran, S. T., Princy, J., & Chandrasekaran, P. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100042 · Cited by 3
Neurological Reaction to Food Additives: Neurotoxic Effects of Food Additives
Yoo, J.-K. (2024) · Food science and nutrition · doi:10.5772/intechopen.114358 · Cited by 6
Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome
Plotnikova, E. Y. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-21-144-150 · Cited by 3
Dehestani, B., & le Roux, C. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070942 · Cited by 3
Khosravany, Z., Khodavaisy, S., Olyaiee, A., Sadeghi, A., Nemati, S., Shahrokh, S., Gol, S. M. A., Shojaei, S., Rahimi, H. M., & Mirjalali, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1514587 · Cited by 5
Piskorz, M. M., stefanolo, J. P., Ibáñez, A. M., Hesse, E., Velez, G. B., Tévez, A., Gutierrez, C., Uehara, T. N., Hashimoto, H., Puga‐Tejada, M., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002123 · Cited by 3
Belladonna Alkaloids and Phenobarbital Use in the Treatment of Irritable Bowel Syndrome: A Review
Panas, R. M. (2019) · doi:10.31531/edwiser.jcegh.1000102 · Cited by 1
Na, W., & Sohn, C. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.6.1201 · Cited by 3
“The factors that exacerbate IBS include changes in gut motility and sensitivity, changes in the intestinal flora, dysregulation of the gut-brain axis, dietary factors, socio-psychological and genetic factors, and stress [2-5].”
BackgroundAndafa, T. W., Imoh, E. C., & Adekanmbi, S. A. (2026) · Cureus · doi:10.7759/cureus.109142 · Cited by 1
The Emerging Role of Microbiome–Gut–Brain Axis in Functional Gastrointestinal Disorders
Skonieczna‐Żydecka, K., Łoniewski, I., Koulaouzidis, A., & Marlicz, W. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00026-9 · Cited by 1
Benefits and safety of probiotics in gastrointestinal diseases
Profir, M., Roşu, O. A., Ionescu, R. F., Pavelescu, L. A., & Creţoiu, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824472-2.00011-7 · Cited by 5
Чернявський, В. В., Руденко, М. М., & Baylo, A. E. (2018) · Family Medicine · doi:10.30841/2307-5112.6.2018.168481
Dutra, D. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-20032020-141735
Irritable bowel syndrome and the brain-gut connection
Pawlik, L., & Tarasiuk, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00003-4 · Cited by 1
Xuan, L., Zhou, J., Yi, L., & Xu, S. (2020) · Pteridines · doi:10.1515/pteridines-2020-0016
“Recently, the central nervous system (CNS) has been identified as a key component in the development of IBS [2-4].”
Black, C. J. (2021) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Nutrition and the Function of the Central Nervous System
Hammond, B. R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-052-1
Editorial overview: gastrointestinal regulatory peptides
Weber, H. C. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000450
Lee, J. H., Sung, W.-S., Bak, S. B., Kim, E., & Kim, Y. W. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102152
Beyond the Digestive System: Understanding Gut-Brain-Microbiome Axis in Irritable Bowel Syndrome
Khosa, R. A., Zaidi, S. I. H., Jaffri, M. S. A., Mehmood, S., & Bakhsh, A. (2023) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2023186
Metadata
- Authors
- Quigley, E.
- Affiliations
- Houston Methodist (US)
- Corresponding author
- Quigley, Eamonn
- ORCID
- Quigley, Eamonn
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-01-03
- Volume
- 7
- Issue
- 1
- Pages
- 6
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5791014
- OpenAlex
- W2781963884
- Semantic Scholar
- d793c9c7b988b71a9f0543b0a9db66da6b4ecfba
- Cited by
- 109
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 12 · 2023: 6 · 2022: 22 · 2021: 12 · 2020: 14 · 2019: 16 · 2018: 12
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, gut-brain axis, microbiota-gut-brain axis, gut microbiota, dysbiosis, enteric nervous system, gut immune system, IBS pathophysiology, IBS management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.